-

Kirby McInerney Announces $6.5 Million False Claims Act Settlement against a Medical Practice that Paid Kickbacks for Patient Referrals through False “Rental” Agreements

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is proud to announce that a False Claims Act whistleblower case it brought has resulted in a $6.5 million settlement and the defendant’s exclusion from government-funded healthcare programs.

On behalf of its client, Kirby McInerney filed the False Claims Act qui tam (whistleblower) lawsuit in 2018 against the radiology practice Gramercy Cardiac Diagnostic Services P.C. and its founder, owner, and principal Dr. Klaus Peter Rentrop. The complaint alleged that these defendants violated the federal and New York State False Claims Acts by paying kickbacks, disguised as rental agreements, to pay large numbers of doctors for referring patients to their radiology business.

After Kirby McInerney filed the whistleblower case, the federal and New York State governments investigated and decided to intervene in the case and pursue the claims. They negotiated a settlement with Gramercy Cardiac and Dr. Rentrop based on their ability to pay, rather than on the much larger amount they had falsely billed to the government.

As part of the settlement, Gramercy Cardiac and Dr. Rentrop will pay the government $6.5 million and have admitted to their misconduct. In addition, Dr. Rentrop will be excluded from participating in government-funded healthcare programs such as Medicare and Medicaid.

“Gramercy Cardiac and Dr. Rentrop’s kickback scheme was a way to divert taxpayer dollars into their own pockets without regard to the health of their patients and the integrity of the government programs. We are proud to have stopped them,” said Randall Fox, who handled the case for Kirby McInerney together with David Kovel.

The multi-year kickback scheme was brought to light by Kirby McInerney’s client, a physician to whom Gramercy Cardiac and Dr. Rentrop unsuccessfully marketed their scheme. Under the False Claims Act, whistleblowers can receive as awards a share of the government’s recovery.

Mr. Fox added “This case shows that an effective whistleblower does not need to be an insider. The key is that the person has useful, concrete, provable information that the defendant was engaging in wrongful conduct. Here, the defendants’ kickback scheme could work only if they enlisted doctors to refer patients. Their marketing of the illegal scheme led to its unraveling.”

Kirby McInerney extends its gratitude to its client and the United States Attorney’s Office for the Southern District of New York and the New York State Attorney General’s Medicaid Fraud Control Unit for investigating and pursuing this case. In particular, it thanks Assistant United States Attorney Jacob Lillywhite and Special Assistant Attorney General Hillary Chapman and their teams for leading the case to its successful conclusion.

If you are aware of violations that have victimized the government or investors that might be addressed by a whistleblower program, please contact Kirby McInerney LLP partners Randall Fox by email at rfox@kmllp.com or David Kovel at dkovel@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in whistleblower, securities, antitrust, and consumer litigation. The firm’s efforts to protect the integrity of government and investors’ dollars have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website and its whistleblower website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Randall M. Fox, Esq.
rfox@kmllp.com
David Kovel, Esq.
dkovel@kmllp.com
(212) 371-6600
https://www.kmllp.com
https://www.whistleblower.kmllp.com

Kirby McInerney LLP


Release Versions

Contacts

Kirby McInerney LLP
Randall M. Fox, Esq.
rfox@kmllp.com
David Kovel, Esq.
dkovel@kmllp.com
(212) 371-6600
https://www.kmllp.com
https://www.whistleblower.kmllp.com

More News From Kirby McInerney LLP

PHR INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Phreesia, Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) investors of the July 13, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Phreesia securities between May 8, 2025 through March 30, 2026 (“the Class Period”).Courts do not consider applications filed after the lead plaintiff deadline. The lead plaintiff oversees the litigation on behalf of the...

INVESTOR ALERT: Securities Class Action Filed Against Lucid Group, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Lucid Group, Inc. (“Lucid” or the “Company”) (NASDAQ:LCID) securities during the period of February 25, 2026 through April 13, 2026, inclusive (“the Class Period”).If you suffered a loss on your Lucid investments, you have until July 28, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after...

YSS INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving York Space Systems Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of York Space Systems Inc. (“York Space Systems” or the “Company”) (NYSE:YSS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?York Space Systems completed its initial public offering (“IPO”) in January 2026, selling 18,500,00 shares...
Back to Newsroom